Stay updated on Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial
Sign up to get notified when there's something new on the Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial page.

Latest updates to the Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a minor revision update, from v3.4.1 to v3.4.2, with no changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing Revision: v3.4.0 in the revision metadata.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded glossary display and updated metadata labels: 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with Revision: v3.4.0. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the older Revision: v3.3.4.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; this appears to be a minor documentation update. There are no observed changes to study content, eligibility criteria, or results.SummaryDifference0.0%

- Check68 days agoChange DetectedA unified Locations section has been added, including New South Wales and Tasmania, and the separate NSW and Tasmania location sections have been removed.SummaryDifference0.2%

- Check75 days agoChange DetectedOvarian cancer is now listed as a topic and MedlinePlus Genetics is added as a related topic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial page.